Annual report for 2022 for Medistim ASA

30 Mar 2023 17:42 CEST

(Oslo, 30th of March 2023) Medistim ASA (OSE: MEDI), a niche market leader
within ultrasound technology with headquarter in Norway, that develops and
commercializes medical equipment for use within cardiac, vascular and transplant
surgery, announces that the Annual Report for 2022 is approved and available.

About Medistim:
Medistim was established in 1984, and has a track record of profitable growth
over the past >15 years. The company is a pioneer within its segment, and
continues to invest in new product development. Medistim has wholly owned
subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark,
Canada and Norway, in addition to the about 60 distributors in Europe, Asia,
Middle East, Africa, and South America. For more information, visit the Medistim
home page: www.Medistim.com

This information is disclosed under Norwegian law (Verdipapirhandelloven §5-12).
For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com

More information:
Access the news on Oslo Bors NewsWeb site

586740_Annual report Medistim ASA 2022.pdf
586740_5967007LIEEXZXJOX483-2022-12-31-en.zip